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Several halogenated alkenes are nephrotoxic; some others induce renal tubular adenocarcinomas in
rodents after lifelong administration. A bioactivation mechanism accountingforthe organ-selective tumor
induction has been elucidated: conjugation of the parent compounds with glutathione (GSH), catalyzed
by hepatic GSH S-transferases, results in the formation of haloalkyl and halovinyl glutathione S-conju-
gates. Formation ofS-conjugates (identified by NMR and mass spectrometry) could be demonstrated with
trichloroethene, tetrachloroethene, hexachlorobutadiene, perfluoropropene, trichlorotrifluoropropene,
and dichloroacetylene in incubations with rat liver microsomes and in the isolated perfused rat liver. The
GSH conjugates formed are eliminated from the rat liver with the bile and may be translocated to the
kidney, intact or after metabolism to the corresponding cysteine S-conjugates that are metabolized in the
kidney by renal tubular cysteine conjugate 3-lyase (P-lyase) to reactive intermediates, most likely thioa-
cylchlorides and thioketenes. Interaction of these potent electrophiles with DNA [demonstrated for in-
termediates formed from S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine] causes mutagenicity in bacteria,
genotoxicity in cultured renal cells, and cytotoxicity in kidney cells. As an alternative to 3-lyase-catalyzed
cleavage, the cysteineS-conjugates may be acetylated to the corresponding mercapturic acids, which have
been identified in urine. The ability of the kidney to concentrate GSH and cysteine S-conjugates and the
intensive metabolism ofGSH S-conjugates to cysteine S-conjugates in this organ are evidently responsible
for the organotropic carcinogenicity.
Introduction
Several halogenated alkenes, e.g., hexachlorobuta-
diene (HCBD), perfluoropropene (PFP), trichlorotri-
fluoropropene (TCTFP), and the alkyne dichloroacety-
lene (DCA), are selectively nephrotoxic in rats and
induce proximal tubular damage (1). Moreover, the
widely used solvents trichloroethene and tetrachlo-
roethene, DCA, and HCBD induce carcinoma of the
proximal tubules in rats. Recent studies that have
sought an explanation for the selective nephrotoxicity
and carcinogenicity ofthese compounds have elucidated
a bioactivation mechanism that involves glutathione
(GSH) S-conjugate formation, translocation to the kid-
ney before or after metabolism to the corresponding
cysteine S-conjugates, and, finally, metabolismbyrenal
cysteine conjugate 3-lyase to yield pyruvate, ammonia,
and reactive electrophiles presumably responsible for
the nephrotoxicity of the parent compounds and the
cytotoxicity ofthe derived amino acid S-conjugates (2).
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The hypothesis that the nephrotoxicity of halogenated
alkenes maybeattributable tohepatic GSHS-conjugate
formation and, ultimately, to bioactivation by renal cys-
teine conjugate 13-lyase has been validated experimen-
tally.
Biosynthesis of GSH S-Conjugates
and Mercapturic Acids from
Haloalkenes and Dichloroacetylene
Fluoroalkenes are reasonably good substrates for he-
patic GSH S-transferases and are metabolized by ad-
dition ofGSH to the alkene double bond (1). With PFP,
both saturated and vinylic GSH S-conjugates are
formed (Dekant et al., unpublished). Chloroalkenes are
transformed to chlorovinylic GSH S-conjugates; the al-
kyne DCA adds GSH by enzymatic catalysis to give S-
(1,2-dichlorovinyl) glutathione.
The reaction rates observed in vitro are well corre-
lated to the chemical reactivity ofthe haloalkene (Table
1). In fluoroalkenes, the carbon-carbondouble bond eas-
ily adds nucleophiles since it is not resonance stabilized;
in TCTFP, stabilization of the intermediate carbanion,
formed by reaction of the olefin with GS- by the tri-DEKANT ETAL.
Table 1. Reaction rates for the GSH S-transferase-catalyzed conjugation of haloalkenes and dichloroacetylene with GSH in rat liver
microsomes and rat liver cytosol.a
nmole S-conjugate/min/mg protein
Haloalkene Product formed Microsomes Cytosol Reference
Trichloroethene S-(1,2-dichlorovinyl) GSH 0.002 (12)
Tetrachloroethene S-(1,2,2-trichlorovinyl) GSH 0.23 0.13 (16)
Hexachlorobutadiene S-(1,2,3,4,4-pentachlorobutadienyl) GSH 1.12 0.04 (17)
Perfluoropropene S-(1,1,2,3,3,3-hexafluoropropyl) GSH 36 (18)
S-(1,1,2,3,3-pentafluoropropenyl) GSH 240 136
Trichlorotrifluoropropene S-(1,2-dichloro-3,3,3-trifluoropropenyl) GSH 530 120 (19)
Dichloroacetylene S-(1,2-dichlorovinyl) GSH 3160 660 (20)
aGSH, lOmM.
fluoromethyl substituent, increases reactivity of this
chloroolefin with nucleophiles. Substitution with chlor-
ine results in stabilization of a wn-bond; chloroalkenes
are more resistant to metabolism by GSH conjugation
than fluoroalkenes.
Withallhalogenated hydrocarbon substrates studied,
the extent ofGSHS-conjugate formationismuchhigher
with liver microsomes than with liver cytosol (2), a re-
versal of the situation observed with most other sub-
strates for GSH S-transferases. This effect may be due
to a preferential distribution ofthe highly lipophilic hal-
oalkenes into lipid membranes, thus generating high
substrate concentrations for the membrane-bound en-
zymes.
In rats, metabolites indicative of GSH S-conjugate
formation have also been identified. In the bile of rats
exposed to trichloroethene, tetrachloroethene, HCBD,
TCTFP, or PFP, GSH S-conjugates identical to those
formed in liver microsomes were present; in urine of
exposed animals, halovinylmercapturic acids were de-
finitively identified, demonstrating that GSH S-conju-
gate formation occurs in vivo (2).
Genotoxicity of S-Conjugates in
Bacteria
Chlorovinyl-substituted cysteine S-conjugates are
mutagenicintheAmespreincubationtestintheabsence
ofactivating enzymes (3). These cysteine S-conjugates
are converted to reactive intermediates and pyruvate
by P-lyase present in the Salmonella typhimurium
strainused. GSHS-conjugates derivedfromchlorinated
alkenes require processing by y-glutamyl transpepti-
dase (GGT) and dipeptidases to yield cysteine S-con-
jugates as penultimate toxic intermediates. Accord-
ingly, the GSH S-conjugates derived from HCBD,
trichloroethene, tetrachloroethene, TCTFP, and DCA
were definite mutagens intheAmestestinthe presence
ofrat kidney particulate fractions containing high GGT
and dipeptidase activities.
Toevaluate thegenotoxicity ofGSHS-conjugatesand
cysteine S-conjugates in mammalian cells, the bioacti-
vation and detoxication mechanisms, transport prop-
erties, and DNA repair capabilities in renal proximal
tubular cells were studied by using an essay to deter-
mine unscheduled DNA-synthesis (UDS) in a porcine
kidney cell line (LLC PK1) (4,5). All halovinyl GSH and
cysteine S-conjugate tested induce GGT and ,B-lyase-
dependent non-S-phase uptake of 3H-thymidin, indica-
tive of DNA damage in LLC PK1 cells. UDS induction
occurs at concentrations of S-conjugates that do not
cause severe cytotoxicity and cell death. However, the
extentofDNArepairobserved was quite lowand, more
important, the concentration range in which UDS could
be observed in the absence of cytotoxicity was very
smallin comparison with the effects ofpotent alkylating
agents.
Reactive Intermediates Formed from
Haloalkene-derived S-Conjugates by
,-Lyase and Their Interaction with
Nucleic Acids
3-Lyase-catalyzed cleavage of haloalkene-derived S-
conjugates yields pyruvate, ammonia, and reactive in-
termediates whose structures have been recently elu-
cidated. Two experimental approaches were developed
to define the chemical nature of the intermediates
formed (Fig. 1): Reactiveintermediates weregenerated
from S-conjugates by 3-elimination and transformed to
stable, characterizable products (6,7); and chlorinated
enethiols, the initial metabolites formed from S-conju-
gates, were generated nonenzymatically in an inert sol-
vent, and reactive intermediates were trapped and
characterized.
Metabolism of halovinyl S-conjugates by bacterial ,3-
lyase and by an N-dodecyl-pyridoxal bromide-based
model system yielded halogenated acids. Reactions in
the presence ofdiethylamine to transform intermediate
acylating agents to stable products yielded the corre-
sponding thioamides.
Cleavage of the sulfur-sulfur bond in chlorovinyl-2-
nitrophenyl disulfides yields a-chlorinated enethiols
(Fig. 1), as does metabolism of cysteine S-conjugates
by P-lyase (2). The reduction of the sulfur-sulfur bond
can be performed in inert solvents, and reactive inter-
mediates formed can thus be studied without protein
interaction orhydrolysis. To distinguish between thioa-
cylchlorides and thioketenes as potential reactive in-
termediates, theabilityofthecarbon-sulfurdoublebond
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FIGURE 1. Strategy for the identification of reactive intermediates
formed from cysteine S-conjugates by 3-lyase.
to undergo Diels-Alder reactions with cyclopentadiene
was used. When pentachlorobutadienyl 2-nitrophenyl
disulfide was reduced in the presence of cyclopenta-
diene, a cyclopentadiene adduct indicative of a thioke-
tene intermediate was identified (Fig. 1). In summary,
these results suggest that thioketenes are the ultimate
reactive intermediates formed by 3-lyase-dependent
metabolism of cysteine S-conjugates and that their in-
teraction with macromolecules is responsible for S-con-
jugate induced cytotoxicity and DNA-damage.
The reactive intermediates formed from cysteine S-
conjugates also modify DNA both in vitro and in vivo.
DNA isolated from rat kidney cells and bacteria treated
with 35S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine
(PCBC) (8) contained radioactivity, and when this DNA
was hydrolyzed to 3'-deoxynucleotides and separated
by HPLC, three distinct radioactive metabolites were
detected, which probably present DNA constituents al-
tered by PCBC metabolites.
Hydrolysis of mitochondrial DNA (9) obtained from
the kidneys of mice treated with '4C-HCBD followed
by HPLC separation suggested the presence ofaltered
DNA constituents with chromatographic properties
identical with those observed with DNA constituents
modified by 35S-PCBC. These results demonstrate that
reactive intermediates formed by ,-lyase-catalyzed
cleavage of cysteine S-conjugates interact with DNA
both in vitro and in vivo.
Importance of S-Conjugate
Formation and Metabolism for
the Nephrocarcinogenicity
of Halogenated Alkenes
The organ-specific toxicity ofhalogenated alkenes in-
tensively metabolized by S-conjugate formation is de-
termined by two factors: a) the ability of the nephron
to concentrate amino acid derivatives, thus generating
high concentrations of 3-lyase substrates in the target
cells for toxicity and carcinogenicity (10); b) the distri-
bution of GSH S-conjugate processing enzymes. GSH
S-conjugates require processing by GGT and dipepti-
dases prior to ,B-lyase-dependent bioactivation (1). GGT
in mammals is mainly concentrated in the brush-border
membrane of the proximal tubular cells. This enzyme
distribution may also contribute to an increase in the
concentration of cysteine S-conjugates in the target
cells.
The importance of GSH-dependent metabolism of
trichloroethene and tetrachloroethene for the nephro-
carcinogenicity ofthe parent compounds cannot be pre-
cisely defined at present. The amounts ofS-conjugates
formed and bioactivated by ,B-lyase seem small and rel-
ativelyinsignificant (11,12). However, as described pre-
viously for the potent nephrotoxin HCBD, where only
a small fraction of the HCBD given is bioactivated in
the kidney (13), the contribution of the GSH S-conju-
gate/,3-lyase pathway may result in nephrocarcinogen-
icity for trichloroethene and tetrachloroethene too, es-
pecially under the conditions of long-term bioassays
with high doses. Moreover, trichloroethene inhibits its
oxidative metabolism by suicidal inactivation of cyto-
chrome P-450 (14); GSH conjugation reactions may,
therefore, play amoreimportant role intrichloroethene
and, perhaps, alsotetrachloroethene metabolism during
long-term application of high doses than it does in the
single dose metabolism studies carried out to date.
Trichloroethene, tetrachloroethene, and HCBD in-
crease the incidence ofrenalneoplasms in rats, but only
at doses that also induce severe nephrotoxicity. Tumor
induction was not observed after nontoxic doses. In ad-
dition, trichloroethene and tetrachloroethene induce a
low rate of renal tumors exclusively in male rats.
The formation of S-conjugates and their renal acti-
vation by 13-lyase may be involved in this organ-specific
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tumor induction. The S-conjugates formed are potent
,B-lyase-dependent mutagens in bacteria, and they in-
duce DNA damage in mammalian cells. They are, how-
ever, also highly cytotoxic in renal proximal tubular
cells. These in vitro results, the very low level ofgen-
otoxicity of HCBD in the kidney in vivo (15), and the
severe chronicnephrotoxicity observed in long-termtu-
morigenicity studies indicate that both genotoxic and
nongenotoxic mechanisms might contribute to haloal-
kene nephrocarcinogenicity. The DNA damage induced
by cysteine S-conjugates of haloalkenes and the ob-
served binding of HCBD-metabolites to renal DNA,
however, suggests that genotoxic mechanisms are op-
erative in the carcinogenicity ofthese haloalkenes.
This work was supported by the Deutsche Forschungsgemein-
schaft, Bonn, SFB 172.
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